ArticleFrontiers in immunology2026

A real-world, triple-cohort study on the effectiveness and safety of telitacicept in immunosuppressant-naïve and refractory lupus nephritis.

Suren Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.